Millennium Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,957,600
| Closed | -$77M | – | 6864 |
|
|
2023
Q2 | $77M | Buy |
1,957,600
+1,906,700
| +3,746% | +$67.3M | 0.04% | 487 |
|
|
2023
Q1 | $1.24M | Buy |
+50,900
| New | +$1.11M | ﹤0.01% | 3893 |
|
|
2022
Q4 | – | Sell |
-527,800
| Closed | -$9.47M | – | 7315 |
|
|
2022
Q3 | $9.47M | Buy |
527,800
+377,800
| +252% | +$4.96M | 0.01% | 2217 |
|
|
2022
Q2 | $1.44M | Buy |
150,000
+138,100
| +1,161% | +$1.73M | ﹤0.01% | 4028 |
|
|
2022
Q1 | $200K | Buy |
+11,900
| New | +$176K | ﹤0.01% | 5822 |
|
|
2021
Q4 | – | Sell |
-160,000
| Closed | -$2.6M | – | 7599 |
|
|
2021
Q3 | $2.6M | Buy |
+160,000
| New | +$1.74M | ﹤0.01% | 3602 |
|
|
2017
Q1 | – | Sell |
-19,000
| Closed | -$92K | – | 3944 |
|
|
2016
Q4 | $92K | Buy |
19,000
+8,000
| +73% | +$237K | ﹤0.01% | 3204 |
|
|
2016
Q3 | $507K | Buy |
+11,000
| New | +$620K | ﹤0.01% | 2597 |
|
|
2014
Q1 | – | Sell |
-2,900
| Closed | -$94K | – | 3985 |
|
|
2013
Q4 | $94K | Buy |
+2,900
| New | +$86K | ﹤0.01% | 3345 |
|
Millennium Management's ISEE Position: Q3 2023 in Review
Millennium Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 3,959,870 shares — an estimated $156M sold.
Millennium Management first reported a position in ISEE in Q4 2013 and held it in 36 quarters. The position peaked at $156M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Millennium Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Millennium Management sold 3,959,870 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $156M.
- Millennium Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
- Millennium Management's IVERIC bio, Inc. Common Stock position peaked at $156M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.